The National Drug Authority (NDA) of Uganda, with funding from the U.S.
Agency for International Development’s Uganda Mission through the Rational
Pharmaceutical Management Plus Program of Management Sciences for Health, held a
national consultative workshop to discuss NDA’s action plan for implementation
of the new antimalarial medicine policy, which includes artemisinin-based
combination therapy as first-line treatment for uncomplicated malaria.
A team of 28 stakeholders was drawn from national and support agencies in
Uganda for a two day workshop (October 4–5, 2006). The workshop targeted
stakeholders providing support for the new antimalarial treatment policy by
executing malaria control and pharmaceutical management activities. Participants
included researchers, policy makers, clinicians, pharmacists, procurement
specialists, and district health workers, as well as members or staff from
health professional associations, development partners, and agencies responsible
for implementing public health policy.